Filing Details
- Accession Number:
- 0001209191-15-077347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-30 10:31:34
- Reporting Period:
- 2015-10-28
- Filing Date:
- 2015-10-30
- Accepted Time:
- 2015-10-30 10:31:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-10-28 | 10,400 | $35.64 | 355,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-10-28 | 1,200 | $117.25 | 354,484 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-28 | 2,144 | $118.30 | 352,340 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-28 | 4,356 | $119.10 | 347,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-28 | 2,600 | $120.18 | 345,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-28 | 100 | $121.47 | 345,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-10-28 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 136,000 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $117.25 (range $116.65 to $117.53).
- Open market sales reported on this line occurred at a weighted average price of $118.30 (range $117.65 to $118.52).
- Open market sales reported on this line occurred at a weighted average price of $119.10 (range $118.71 to $119.64).
- Open market sales reported on this line occurred at a weighted average price of $120.18 (range $119.71 to $120.65).
- Fully vested.
Billionaire Hedge Funds
